Get the Stockscreener App
0.2584
4.53%
-0.0167
AEON Biopharma Inc. stock is traded at $0.2584, with a volume of 392.36K.
It is down -4.53% in the last 24 hours and down -10.94% over the past month.
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.
See More
Previous Close:
$0.2751
Open:
$0.2778
24h Volume:
392.36K
Relative Volume:
0.39
Market Cap:
$12.78M
Revenue:
-
Net Income/Loss:
$-60.11M
P/E Ratio:
-0.0594
EPS:
-4.347
Net Cash Flow:
$-12.04M
1W Performance:
-5.32%
1M Performance:
-10.94%
6M Performance:
-72.92%
1Y Performance:
-65.80%
1-Day Range:
$0.2564
$0.284
1-Week Range:
$0.2564
$0.285
52-Week Range:
$0.2222
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
Name
AEON Biopharma Inc.
Sector
Industry
Phone
(949) 354-6499
Address
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.2616 | 13.44M | 0 | -60.11M | -12.04M | -4.347 |
VRTX
Vertex Pharmaceuticals Inc
|
516.25 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.82 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
992.77 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
215.15 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.23 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-18-23 | Initiated | H.C. Wainwright | Buy |
AEON Biopharma Inc. Stock (AEON) Latest News
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution By Investing.com - Investing.com UK
H.C. Wainwright cuts Aeon Biopharma stock price target on dilution - Investing.com
H.C. Wainwright Maintains AEON Biopharma(AEON.US) With Buy Rating, Cuts Target Price to $1.2 - Moomoo
AEON Biopharma Q2 EPS $(0.02) beats $(0.12) estimate - scanx.trade
AEON Biopharma Reports Q2 Results, Advances ABP-450 Program - TipRanks
AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
AEON Biopharma Q2 net loss narrows on warrant gain; cash runway extended - TradingView
AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON Biopharma Regains NYSE American Listing Compliance - TipRanks
AEON Biopharma Regains NYSE American Compliance After Completing Public Offering - Quiver Quantitative
AEON Biopharma (NYSE American: AEON) lifts .BC indicator after $13.6M equity raise - Stock Titan
AEON Biopharma, Inc. Revenue Breakdown – AMEX:AEON - TradingView
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AEON|Aeon Biopharma Inc|Price:0.257|Chg%:+0.006 - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Income Statement - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Bitget Launchpool adds AEON (AEON) with 1.1M in Token Rewards - GlobeNewswire Inc.
Aeon Biopharma Inc (AEON) Balance Sheet - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Cash Flow - TradingKey
AEON Biopharma, Inc. Revenue Breakdown – BOATS:AEON - TradingView
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AEON|Aeon Biopharma Inc|Price:0.228|Chg%:-0.023 - TradingKey
AEON Biopharma boosts liquidity with additional share sale - The Globe and Mail
AEON Biopharma says underwriters fully exercise milestone warrant over-allotment option for 6,403,290 shares - Bitget
Stonepine Capital group discloses 9.9% AEON Biopharma (AEON) ownership via stock and warrants - Stock Titan
AEON Biopharma Inc. (AEON) Hovers Near Support as Bearish Pressure PersistsMutual Fund Flow - dars.gov.et
NFA- today's 8K - Moomoo
AEON Biopharma (NYSE American: AEON) prices $13.75M stock and milestone warrant sale - Stock Titan
AEON Biopharma (NYSE American: AEON) sells stock and milestone-tied warrants - Stock Titan
AEON BiopharmaOffering Includes 42.69 Mln - Moomoo
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding - The Manila Times
AEON Biopharma Could Raise $29.6M More Through Warrants - Stock Titan
AEON Biopharma, Inc. SEC Filing (Jul 14, 2026) - Stock Titan
Trending Stocks Today | Vision Marine Technologies Shoots up 100.7% Pre-Market - Moomoo
AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan
AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants - Moomoo
AEON Q4 2025 Earnings: EPS Misses Estimates; No Revenue as Company Advances PipelineSubscription Growth Report - po-news-eg.net
Form S-1 Aeon Biopharma Inc For: 8 July By Investing.com - Investing.com Nigeria
AEON Biopharma (AEON) files S-1 for $11M stock sale plus milestone warrants - Stock Titan
AEON Biopharma Q4 2025 Earnings: Wider-Than-Expected Loss Underscores Pre-Revenue ChallengesQuarterly Financial Update - dars.gov.et
AEON Q4 2025 Earnings: Wider Loss Misses Estimates Amid Pre-Revenue StageDownward Estimate Revision - dars.gov.et
AEONAEON Biopharma Inc Latest SEC Filings - Finviz
AEON Biopharma (AEON) Edges Higher Amidst Volatile TradingAlgorithmic Stock Picks - po-news-eg.net
Price to book forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
Price to sales forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
AEON Biopharma Inc. Stock (AEON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Cap:
|
Volume (24h):